Preventis MyHealthscore

myHealthScore is a genetic test that provides information about a patient’s risk of common multifactorial diseases. The test analyses polygenic risk providing detection for a larger number of people.

The panel covers -

• Breast cancer (if female) Prostate cancer (if male)
• Cardiovascular PRS
• Type 2 Diabetes

What is polygenic risk?

The most common diseases are often multifactorial in origin meaning that they are caused by the effect of genetics together with other factors such as lifestyle and environment.

In these cases, the genetic risk is not usually associated with a single variant but with thousands or even millions of common variants throughout the genome. This is known as a polygenic risk.

Who is it intended for?

The test is suitable for adults who are proactive about their healthcare. The results provide information about the lifetime risk of presenting the diseases analysed in order to establish preventive strategies and lifestyle changes that will help to reduce the risk.

Additionally, a basic ancestry analysis is completed to adjust the risk analysis based on the patient’s genealogy.

Advantages of myHealthScore

The software for the analysis is CE-marked and enables the risk evaluation of presenting different pathologies, providing the specialist with important information for your healthcare

Why is myHealthScore important?

• Allows the quantification of the aggregated genetic risk, scattered along the genome, associated with a particular disease.
• The test is performed once in a lifetime, estimating the risk of disease and how it varies throughout life in comparison with the general population.
• It can be carried out before the onset of clinical risk factors, which allows for a more effective preventive approach.
• There are calculators that establish the risk of cardiovascular disease and cancer. Incorporating myHealthScore results into these calculators improves their predictive power. Veritas provides physicians access to the risk calculators for cardiovascular disease and breast cancer.
• •Information that is independent and complementary to traditional risk factors and the study of genetic panels.

1 out of every 4 people with coronary artery disease is undetected through the evaluation of clinical risk factors.

7 out of every 10 women diagnosed with breast cancer do not have a family history of the disease.

8 out of 10 people with pre-diabetes are not aware of their condition and the possibilities for prevention

The clinical care provided by Preventis consists of -

• A 30 minute pre test counselling session with an accredited genetic counsellor
• Support through out the whole process
  
• The Veritas Genetics lab reports (CanRisk reports can be purchased separately)
• A post test counselling session with an accredited genetic counsellor if a rare positive variant is discovered

The raw sequencing data can be provided at no cost if requested

Read more information about the My Health Score Project here. 

Results should be returned between 6 and 8 weeks from receipt of sample, this can take longer if rare genes that require secondary testing are required.